Latest AI and machine learning research in gastroenterology for healthcare professionals.
Reliable biomarkers that enable noninvasive, longitudinal assessment of disease activity and therapeutic response remain a major unmet need in inflammatory bowel disease (IBD). While colonic biopsies are the gold standard for evaluating mucosal inflammation, their invasive nature and limited spatial and temporal resolution constrain their utility in routine monitoring and clinical trials. Blood-ba...
INTRODUCTION: Despite growing interest, same-day discharge (SDD) after bariatric surgery remains uncommon due to challenges with patient selection. In this study, we seek to evaluate whether Metabolic and Bariatric Surgery Accreditation and Quality Improvement Program (MBSAQIP) database provides sufficient information for predicting SDD candidacy METHODS: In this retrospective cohort study, we ide...
Pancreatic ductal adenocarcinoma (PDAC) is frequently preceded by new-onset diabetes mellitus (NODM), yet differentiating PDAC-associated DM from type...
Autophagy is a self-digestive process in which cellular components are degraded and recycled to maintain homeostasis and cope with stress. When cells ...
Intestinal alkaline phosphatase (IAP) is a brush border enzyme critical for maintaining gut homeostasis by detoxifying bacterial endotoxins, regulatin...
OBJECTIVES: Contrast-enhanced computed tomography (CT) is central to liver imaging. Inadequate enhancement can compromise diagnostic accuracy and impa...
Accurate prognostic prediction remains a critical unmet need in advanced hepatocellular carcinoma (HCC). While machine learning (ML) models have demon...
Medical artificial intelligence (AI) has advanced rapidly, yet a comprehensive quantitative overview of its clinical evaluation landscape remains lack...
The shift from the traditional empirical approach to a more data-driven method in the diagnosis and treatment of GI cancers is significant due to adva...
Objective: To develop and validate machine learning-based models for predicting the risk of transmural irreversible intestinal necrosis (ITIN) in pati...
BACKGROUND: Gastric cancer is an aggressive malignancy with poor prognosis due to complex pathogenesis, underscoring the need for biomarkers and targe...
BACKGROUND: Metabolic dysfunction-associated steatotic liver disease (MASLD) presents a growing global health burden, while reliable non-invasive biom...
OBJECTIVES: Transarterial chemoembolization (TACE) is a promising locoregional therapy for unresectable colorectal liver metastases, but patient selec...
BACKGROUND: Artificial intelligence (AI) is increasingly being implemented in digital pathology to support the tissue classification, cell detection, ...
Pancreatic ductal adenocarcinoma (PDAC) has poor prognosis due to late diagnosis, limitations of computed tomography (CT) imaging, and low accuracy of...
Nonalcoholic fatty liver disease (NAFLD) is the most common chronic liver disease worldwide. While many factors have been associated with NAFLD, their...
PURPOSE: As obesity has reached pandemic proportions worldwide, improving technical solutions for its treatment requires robust planning and numerical...
This study aims to develop and externally validate a multimodal AI model for detecting ischemia complicating small-bowel obstruction (SBO). We combine...
BACKGROUND: Colorectal cancer is a major global health burden, with most cases arising from adenomatous polyps. Although colonoscopy is the gold stand...
BACKGROUND: Ischemic heart disease and metabolic dysfunction-associated steatotic liver disease represent significant global health challenges, charac...